RAPTIVA

Welcome to the Brand page for “RAPTIVA”, which is offered here for In the statement, column 1, lines 7 through 9, cardiovascular diseases and disorders, oncological diseases and disorders, should be deleted, and, in the statement, column 1, lines 10 through 11, angiogenesis diseases and disorders, ocular diseases and disorders is deleted, and, in the statement, column 1, line 13, including crohn's diseases is deleted.;pharmaceutical preparations for the treatment of [ cardiovascular diseases and disorders, oncological diseases and disorders, ] immune diseases and disorders, [ angiogenesis diseases and disorders, ocular diseases and disorders, ] and inflammatory diseases and disorders [ including crohn's diseases, ] all of the above excluding the treatment of gastrointestinal problems and diseases;the mark is not in color, and the color gray in the mark is intended to indicate shading or contrast only.;.

Its status is currently believed to be active. Its class is unavailable. “RAPTIVA” is believed to be currently owned by “Genentech España, S.L.”